Picture of Neuroscientific Biopharmaceuticals logo

NSB Neuroscientific Biopharmaceuticals Balance Sheet

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Neuroscientific Biopharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments3.2914.27.224.914.95
Net Total Accounts Receivable
Net Total Receivables0.0190.0490.1210.0430.054
Prepaid Expenses
Total Current Assets3.3114.47.45.015.04
Net Property, Plant And Equipment0.0090.0280.0170.0090.006
Net Intangible Assets
Total Assets3.7414.87.745.295.44
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities0.0890.2232.220.5970.086
Total Long Term Debt
Total Debt
Total Liabilities0.0890.2232.220.5970.086
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity3.6514.65.524.695.35
Total Liabilities & Shareholders' Equity3.7414.87.745.295.44
Total Common Shares Outstanding